Dashboard
Manage Tickers

AKTXAkari Therapeutics Plc

Nasdaq akaritx.com


$ 3.29 $ 0.11 (3.61 %)    

Friday, 14-Jun-2024 12:46:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 3.16
$ 3.07
$ 0.00 x 0
$ 0.00 x 0
$ 3.07 - $ 3.29
$ 1.08 - $ 5.50
10,424
na
42.51B
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 05-12-2016 03-31-2016 10-Q
4 03-23-2016 12-31-2015 10-K
5 11-23-2015 09-30-2015 10-Q
6 08-12-2015 06-30-2015 10-Q
7 05-12-2015 03-31-2015 10-Q
8 02-11-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 16:31:11

akari-therapeutics-announces--samir-r-patel-md-has-assumed-the-role-of-interim-president--ceo-increases-ownership-to-142-with-125m-investment-in-recent-private-placement
Akari Therapeutics Announces Samir R. Pat...
06/05/2024 12:11:51

Interim CEO employment contract consists solely of equity compensation Samir R. Patel, M.D., increases ownership to 14.2% with ...

akari-therapeutics-secures-76m-in-upsized-financing-round-from-both-new-and-existing-investors
Akari Therapeutics Secures $7.6M In Upsize...
06/04/2024 12:24:46

Akari Therapeutics Plc (NASDAQ:AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory d...

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
05/27/2024 12:05:50

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/24/2024 12:07:16

akari-therapeutics-as-of-march-31-2024-the-company-had-cash-of-13m
Akari Therapeutics As Of March 31, 2024, T...
05/16/2024 12:23:14

akari-therapeutics-said--on-may-1-began-to-implement-a-reduction-in-force-of-approximately-67-of-its-total-workforce
Akari Therapeutics Said- On May 1 Began To...
05/07/2024 21:08:52

-8-K

Core News & Articles
Akari Therapeutics And Peak Bio Announce P...
05/01/2024 12:08:56

Prioritization of Peak's ADC cancer therapeutic platform technology and Akari's PAS-nomacopan for Geographic Atrophy, a...

akari-therapeutics-appoints-samir-patel-as-interim-ceo
Akari Therapeutics Appoints Samir Patel As...
05/01/2024 12:05:20

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

akari-therapeutics-to-present-pas-nomacopan-pre-clinical-electroretinography-data-at-arvo-2024
Akari Therapeutics To Present PAS-Nomacopa...
04/15/2024 12:07:32

akari-therapeutics-cash-of-approximately-38m-as-of-december-31-2023-in-march-2024-it-raised-approximately-2m-via-private-placement-and-is-planning-to-secure-additional-capital-in-q2-of-2024
Akari Therapeutics' Cash Of Approximately ...
04/01/2024 10:35:00

akari-therapeutics-fy2023-eps-000-same-yoy
Akari Therapeutics FY2023 EPS $0.00, Same YoY
04/01/2024 10:34:00

Core News & Articles
Akari Therapeutics And Peak Bio Announce M...
03/05/2024 13:03:41

akari-therapeutics--closes-private-placement-with-existing-investors-for-gross-proceeds-of-2m
Akari Therapeutics Closes Private Placeme...
01/02/2024 13:01:01

akari-therapeutics-presents-poster-on-progress-in-pre-clinical-development-of-long-acting-pas-nomacopan-as-a-potential-treatment-for-geographic-atrophy-at-the-4th-annual-dry-amd-therapeutic-development-conference
Akari Therapeutics Presents Poster On Prog...
11/16/2023 13:18:26

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and infl...

akari-therapeutics-to-present-a-poster-on-pre-clinical-development-of-long-acting-pas-nomacopan-as-a-potential-treatment-for-geographic-atrophy-at-the-4th-annual-dry-amd-therapeutic-development-conference
Akari Therapeutics To Present A Poster On ...
11/06/2023 13:49:06

Akari Therapeutics, Plc (NASDAQ:AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and infl...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
10/30/2023 21:31:09

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
10/13/2023 13:06:02

akari-therapeutics-h1-2023-net-loss-of-299m-versus-108m-a-year-ago-cash-balance-of-approximately-72m-sufficient-to-fund-operations-into-q1-of-2024
Akari Therapeutics H1 2023 Net Loss Of $2....
09/29/2023 12:04:12

Akari Therapeutics (NASDAQ:AKTX) will report on H1 2023.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)